BRAZAUK LTD
Company number 06397296 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: BRAZAUK LTD
1. Financial Health Score: B+
BRAZAUK LTD exhibits robust financial health with excellent liquidity, strong profitability growth, and a solid asset foundation. The company scores highly on most vital metrics, though the significant intercompany loan structure and parent company relationship in the British Virgin Islands introduce a moderate element of complexity and potential risk. The business is thriving operationally, with retained profits nearly doubling year-over-year.
2. Key Vital Signs
| Vital Sign | 2024 Value | 2023 Value | Year-on-Year Change | Health Indicator |
|---|---|---|---|---|
| Total Assets | £4,394,911 | £3,169,483 | +38.6% | 🟢 Strong growth |
| Net Assets | £2,554,690 | £1,700,535 | +50.2% | 🟢 Excellent |
| Cash Position | £4,278,221 | £2,944,674 | +45.3% | 🟢 Very healthy |
| Current Liabilities | £649,233 | £194,673 | +233.5% | 🟡 Needs monitoring |
| Retained Profits | £1,835,720 | £981,565 | +87.0% | 🟢 Outstanding |
| Employees | 7 | 10 | -30% | 🟡 Workforce reduction |
Liquidity Ratios
| Ratio | 2024 | 2023 | Interpretation |
|---|---|---|---|
| Current Ratio | 6.77x | 16.30x | Extremely liquid; can comfortably meet short-term obligations |
| Quick Ratio | 6.59x | 15.13x | Cash alone covers current liabilities 6.6 times over |
| Cash as % of Total Assets | 97.3% | 92.9% | Asset base is overwhelmingly liquid |
Leverage & Solvency
| Metric | 2024 | Interpretation |
|---|---|---|
| Debt-to-Equity Ratio | 0.25x | Low leverage; equity-funded rather than debt-laden |
| Long-term Loan (Parent) | £1,194,319 | SOFR + 1% - market-rate related party financing |
| Share Capital | £718,970 | Unchanged - growth funded through retained earnings |
3. Diagnosis
What the Financial Data Reveals About Business Health
🟢 Healthy Pulse – Profitability Engine Working Efficiently
The most striking symptom in this assessment is the dramatic growth in retained profits – rising from £981,565 to £1,835,720, representing approximately £854,155 of profit generated during FY2024. This is a 87% increase in accumulated reserves, indicating the business has found a profitable operating model in the Brazilian-UK financial corridor. The company is not just surviving; it is thriving and reinvesting earnings into the business.
🟢 Excellent Circulation – Cash Flow is Robust
With £4.28 million in cash representing 97.3% of total assets, BRAZAUK has exceptional liquidity. Think of this as a patient with excellent blood circulation – the lifeblood of the business (cash) is flowing abundantly. The company can comfortably meet all short-term obligations 6.6 times over from cash alone, without needing to liquidate any other assets or rely on debtor collection.
🟡 Elevated Blood Pressure – Current Liabilities Have Risen Sharply
Current liabilities jumped from £194,673 to £649,233 – a 233% increase. While this sounds alarming, context is essential: - Corporation tax of £146,365 reflects strong taxable profits - Other creditors of £435,477 requires monitoring but isn't necessarily problematic - Trade creditors of £47,666 remain modest relative to the cash position
This is akin to a temporary elevation in blood pressure after exercise – it's a natural response to increased activity (profit generation), not necessarily a chronic condition.
🟡 Structural Dependency – Parent Company Relationship
The £1,194,319 long-term loan from Hotwire Holdings Ltd (British Virgin Islands) represents a significant structural feature. While the interest rate (SOFR + 1%) appears commercial, this intercompany dependency means BRAZAUK's financial health is partially tethered to its parent's decisions. If the parent were to call this loan or change terms, it could impact cash flow planning.
🟡 Workforce Contraction – Headcount Reduced
The reduction from 10 to 7 employees (30% decrease) could indicate: - Operational efficiency improvements - Technology-driven scaling - Cost optimisation - Or potentially, a restructuring phase
Given the strong profitability, this appears to be a positive efficiency gain rather than distress-driven cuts.
🟢 Balance Sheet Cleanliness
The absence of significant doubtful debtors, minimal tangible assets (only £3,331 in computer equipment), and clean creditor structure suggest a well-maintained financial position. The deferred tax asset of £129,733 in 2023 has been utilised in 2024 (reduced to £0), indicating the company is generating sufficient profits to absorb previous tax losses.
4. Prognosis
Future Financial Outlook: Positive with Minor Watch Points
The trajectory is clearly upward. Net assets have grown from £598,791 (2022) to £1,700,535 (2023) to £2,554,690 (2024) – a compound annual growth rate of approximately 106% over two years. This is exceptional by any standard.
Favourable Indicators: - The Electronic Money Institution model appears to be generating strong fee and commission income - Cash generation is excellent, providing a buffer against market volatility - The Brazilian market corridor likely offers continued growth opportunities - Low fixed asset base means the business is inherently scalable
Risk Factors to Monitor: - Regulatory risk inherent in financial services (FCA authorisation as an EMI) - Currency exposure between GBP and BRL - Dependency on parent company for long-term financing - Concentration risk if revenue is dependent on a narrow client base
5. Recommendations
Prescriptions for Improved Financial Wellness
-
Diversify Funding Structure – Consider reducing dependency on the parent company loan by exploring alternative financing or accelerating repayment from the substantial cash reserves. The company holds £4.28M in cash against a £1.19M long-term loan – partial early repayment could reduce interest costs and simplify the balance sheet.
-
Cash Deployment Strategy – With 97% of assets in cash, the business may be holding excessive liquidity. Consider: - Strategic investments in technology/platform development - Building a regulatory capital buffer - Evaluating whether some cash could generate higher returns through prudent investment
-
Monitor Creditor Growth – The 233% increase in current liabilities warrants quarterly review to ensure trade creditors and "other creditors" are growing proportionally with revenue, not signalling payment stress.
-
Strengthen Financial Transparency – As a small company filing abbreviated accounts, BRAZAUK doesn't disclose revenue or detailed P&L. For stakeholders, obtaining management accounts showing revenue, margins, and operating costs would provide a more complete health check.
-
Succession & Governance Planning – With a small team of 7 and key person dependency on directors, ensure business continuity plans are in place. The director loan to M. Sacomori (£11,479 at 2.5% interest) should be formally documented and monitored.
-
Review Related Party Arrangements – The intercompany balances with Hotwire Holdings Ltd should be regularly reviewed to ensure terms remain competitive and that the parent relationship doesn't create undue financial vulnerability.